Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity active

RISE Bio TOP10 Active (0000Z0)

Update : 2026.02.10

NAV

15,905KRW

+759.73상승 (5.02%)

Market Price per share (KRW)

15,925KRW

+755상승 (4.98%)

※ t-1 last price

trading volume

184,846shares

AUM

KRW 54billion

Share it

RISE Bio TOP10 Active (0000Z0)

Overview Performance Holdings

KEY POINT

An Active ETF Investing in 10 Key Domestic Pharmaceutical and Bio Companies Expanding Globally

-

KEY POINT

An Active ETF Designed to Quickly Respond to Technological Advancements, Regulatory Changes, Drug Approvals, and Individual Company Events.

-

Basic information

Download trading information

Update : 2026.02.10
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE Bio TOP10 Active ETF
(0000Z0) 		KRX Bio TOP 10 Index 2024.12.24 50,000 54,076,352,631
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
한국씨티은행 15,925
※ t-1 last price 		15,904 184,846
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.5% (Designated participating company : 0.001%, Collective investment : 0.459%, trust : 0.02%, General affairs : 0.02%) End date of the accounting period (If the end of the accounting period is not a business day, the business day immediately preceding it)
Authorized Participants Liquidity Providers
Kiwoom Securities, NH Investment & Securities, KB Securities Kiwoom Securities, NH Investment & Securities, KB Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE Bio TOP10 Active ETF

(0000Z0) 		KRX Bio TOP 10 Index
Inception date Creation Unit
2024.12.24 50,000
AUM(0.1 billion) (KRW) Trustee
54,076,352,631 한국씨티은행
Market Price per share (KRW) iNAV per share (KRW)
15,925
※ t-1 last price 		15,904
Trading Volume (shares)
184,846
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.5% (Designated participating company : 0.001%, Collective investment : 0.459%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
End date of the accounting period (If the end of the accounting period is not a business day, the business day immediately preceding it)
Authorized Participants
Kiwoom Securities, NH Investment & Securities, KB Securities
Liquidity Providers
Kiwoom Securities, NH Investment & Securities, KB Securities

Index Introduction

The 'KRX Bio TOP 10 Index', calculated and announced by the Korea Exchange (KRX), consisting of 10 representative companies within the Bio industry sector listed on the KOSPI and KOSDAQ markets.

View detailed index information

TOP 10 Holdings

Update : 2026-02-10
Rank , Name, proportion table
Rank Name Weight (%)
1 LCB 12.48
2 ABL Bio 11.85
3 OliX 9.66
4 SCD 6.65
5 HANS BIOMED 4.81
6 HanmiPharm 4.53
7 AprilBio 4.49
8 LivsMed 4.30
9 AbClon 4.29
10 ORUM 3.84

proportion by sectors

*The proportion of investment stocks

Update : 2026.02.10
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 97.74
2 Consumer Staples 2.26

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-12-30 2026-01-05 2

Performance

performance

excel download

Update : 2026-02-10

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -2.53 9.40 34.75 44.18 - 3.20 64.94
Benchmark Index -8.37 2.96 13.18 7.42 - 0.01 26.55
Outperformance 5.84 6.44 21.57 36.76 - 3.19 38.39

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.02.09 15,925 4.976상승 15,904.81 5.016상승 9,591.7
2026.02.06 15,170 -5.512하락 15,145.5 -5.327하락 9,592.33
2026.02.05 16,055 -3.078하락 15,997.77 -3.585하락 9,592.54
2026.02.04 16,565 -0.240하락 16,592.66 -0.615하락 9,592.77
2026.02.03 16,605 4.106상승 16,695.38 4.750상승 9,593.01
2026.02.02 15,950 -3.625하락 15,938.3 -3.404하락 9,593.25
2026.01.30 16,550 -4.169하락 16,500.45 -4.706하락 9,593.95
2026.01.29 17,270 0.905상승 17,315.45 1.083상승 9,594.18
2026.01.28 17,115 1.182상승 17,129.77 1.480상승 9,594.39
2026.01.27 16,915 1.075상승 16,879.85 0.836상승 9,594.62
2026.01.26 16,735 11.418상승 16,739.89 11.200상승 9,594.86
2026.01.23 15,020 7.708상승 15,054.14 8.118상승 9,595.47
2026.01.22 13,945 2.273상승 13,923.76 2.395상승 9,595.67
2026.01.21 13,635 -8.826하락 13,598.08 -9.049하락 9,595.86
2026.01.20 14,955 -0.763하락 14,951.09 -0.765하락 9,596.05
2026.01.19 15,070 0.232상승 15,066.47 -0.183하락 9,596.25
2026.01.16 15,035 0.770상승 15,094.53 1.225상승 9,596.85
2026.01.15 14,920 0.878상승 14,911.82 0.818상승 9,597.06
2026.01.14 14,790 -3.553하락 14,790.69 -3.338하락 9,597.27
2026.01.13 15,335 -3.431하락 15,301.58 -3.957하락 9,597.48
2026.01.12 15,880 -2.397하락 15,932.14 -2.360하락 9,597.69

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 LCB KR7141080002 557 12.48 99,257,400
2 ABL Bio KR7298380007 498 11.85 94,221,600
3 OliX KR7226950004 573 9.66 76,782,000
4 SCD KR7000250001 98 6.65 52,920,000
5 HANS BIOMED KR7042520007 857 4.81 38,222,200
6 HanmiPharm KR7128940004 64 4.53 36,032,000
7 AprilBio KR7397030008 600 4.49 35,700,000
8 LivsMed KR7491000006 431 4.3 34,221,400
9 AbClon KR7174900001 558 4.29 34,093,800
10 ORUM KR7475830006 277 3.84 30,553,100
11 D&D Pharmatech KR7347850000 370 3.82 30,340,000
12 SEERS KR7458870003 177 3.53 28,089,900
13 Kolon TissueGene KR8840120008 286 3.52 27,999,400
14 Rznomics KR7476830005 197 3.3 26,240,400
15 VRNI KR7310210000 119 3.3 26,239,500
16 Alteogen KR7196170005 68 3.3 26,248,000
17 원화예금 KRD010010001 25,638,176 3.22 25,638,176
18 PharmaResearch KR7214450009 72 3.05 24,264,000
19 IVTG KR7389470006 324 2.84 22,582,800
20 Mezzion Pharma KR7140410002 117 2.17 17,245,800
21 PROTEINA KR7468530001 110 1.05 8,349,000
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.